Skip to content

Bausch Health

US · BHC #2722 by market cap Listed 1970
8.22 -0.34 -3.97%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:46

Price chart

Pre-market 8.45 -1.29%
After-hours 8.21 -0.12%
8.914.438.222026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on BHC?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +28.9% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 2.0% of float.
  • Analyst tilt is Hold.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A-
ValuationGrowthProfitMomentumHealthAnalyst
Valuation A+

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 5.0x Better than 97%
Price / Sales 0.3x Better than 96%
Growth B+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 8.1% Better than 59%
Net income CAGR (3Y) 39.7% Better than 85%
Free cash flow CAGR (3Y) 3.2% Better than 42%
Profitability C+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 70.7% Better than 83%
Operating margin 21.3% Better than 79%
Net margin 1.5% Better than 31%
Return on equity -442.0% Better than 1%
Return on invested capital 1.5% Better than 32%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 27.6% Better than 98%
6-month return 50.3% Better than 95%
12-month return (ex latest month) 6.8% Better than 42%
Distance below 52-week high 9.1% Better than 86%
Financial Health C

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.5x Better than 39%
Debt to assets 79.1% Better than 3%
Interest coverage 1.2x Better than 30%
Free cash flow / net income 632.5% Better than 94%
Analyst View D-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 0.0% Better than 0%
Upside to average target 9.5% Better than 14%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -1.56%
1M +28.04%
3M +20.70%
6M +49.45%
YTD +18.27%
1Y +37.00%
3Y +16.76%
5Y -68.40%

Key statistics

Price & volume

Prev close
8.56
Open
8.42
Day range
8.12 - 8.56
Avg price
8.22
Volume
3.84M
Turnover
31.60M
Amplitude
5.14%
52-week range
4.33 - 9.04

Valuation

P/E
19.57
P/E (TTM)
-3.65
P/B
-2.32
EPS
0.42
Net profit
157.19M
Net assets
-1.33B

Share structure

Market cap
3.08B
Float cap
2.14B
Shares out
374.27M
Float shares
260.85M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 83% of range
4.33 9.04

9.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-10.19M net over the window

Short interest

Shares short
7.41M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Bausch Health (BHC)?

Bausch Health last traded at 8.22. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Bausch Health's market cap?

About 3.08B.

What is the P/E ratio of Bausch Health?

The trailing twelve-month P/E is -3.65. The Valuation tab shows it against the stock's own five-year range.

Does Bausch Health pay a dividend?

Bausch Health does not currently pay a regular dividend.

Is Bausch Health a buy according to analysts?

The consensus of 3 analysts is a Hold rating, with an average 12-month price target of 9.00, which implies 9.5% upside from the current price. This is not investment advice.

What is Bausch Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Bausch Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:46:13 · For reference only, not investment advice and not tailored to your situation.

Bausch Health discussion 0 comments

Add a comment